Isabelle Kindts

Dr. Isabelle Kindts

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2014 in Strahlentherapie und Onkologie
Verified
Journal Article
Closed access
PDF file
IKIsabelle Kindts
Isabelle Kindts
KSKarin Stellamans
Karin Stellamans
MBMichiel Bonny
Michiel Bonny
NPNikie Planckaert
Nikie Planckaert
LGLaurence Goethals
Laurence Goethals

25 November 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
LMLore Mertens
Lore Mertens
Laura TackLaura Tack
Laura Tack
TBTom Boterberg
Tom Boterberg
JFJörg Fachner
Jörg Fachner
LMLeonardo Muller-Rodriguez
Leonardo Muller-Rodriguez
Philip Robert DebruynePhilip Robert Debruyne
Philip Robert Debruyne
Objectives: This systematic review seeks to provide an in-depth overview of current research on tele-music interventions in supportive cancer care and identifies key areas where further research is warranted. Methods: A comprehensive search was conducted across four electronic databases (Scopus, Embase, Web of Science, and PubMed) without any data restrictions and according to the PRISMA guidelines. The primary outcome measure was the effect of tele-music interventions on psychosocial functioning. Results: Of the 2.043 articles initially identified, nine studies met the inclusion criteria and were selected for qualitative analysis. Among the music interventions, considerable variation was observed regarding delivery format and techniques employed. Most interventions were delivered remotely through Zoom, and in all but one study, a music therapist was involved. Outcome measures addressed various psychosocial and physical symptoms, most frequently anxiety, for which findings were mixed: three studies reported significant reductions, whereas two others observed no or only limited improvement. Conclusions: The results suggest that tele-music interventions are effective in reducing a range of cancer-related symptoms, including stress, anxiety, depression, and pain. However, the heterogeneity in study designs and methodological limitations hampered direct comparison and overall effectiveness assessment. Additionally, digital technologies hold considerable potential for the accessible and cost-effective delivery of music interventions.

18 April 2022 in The Breast
Verified
Journal Article
Open access
PDF file
AVAline Van der Vorst
Aline Van der Vorst
IKIsabelle Kindts
Isabelle Kindts
ALAnnouschka Laenen
Annouschka Laenen
Patrick NevenPatrick Neven
Patrick Neven
HJHilde Janssen
Hilde Janssen
CWCaroline Weltens
Caroline Weltens
• Post-mastectomy radiotherapy. • Scoring system by Cheng et al. • Based on 4 factors. • Age, estrogen receptor, lymphovascular status, affected axillary lymph nodes. • Intermediate and high-risk patients could benefit from post-mastectomy radiotherapy.

27 April 2026 in BMC Cancer
Verified
Journal Article
Open access
TQTom Quisenaerts
Tom Quisenaerts
IAIlse Van Der Auwera
Ilse Van Der Auwera
PPPhilip M.P. Poortmans
Philip M.P. Poortmans
DRDries Reynders
Dries Reynders
LDLoïc Van Dieren
Loïc Van Dieren
MMMelanie Machiels
Melanie Machiels
Currently there is a wide practice variation in breast reconstruction surgery after mastectomy for breast cancer patients, especially when radiation therapy (RT) is involved. While it is clear from the scientific literature that immediate implant-based reconstruction has an increased complication rate when postmastectomy Radiation therapy (PMRT) is administered, the jury is out on autologous immediate breast reconstructions (IBR). Nevertheless, some clinicians avoid autologous IBR due to aesthetic outcomes being negatively influenced by PMRT. Others only place tissue expanders, or avoid IBR altogether, when PMRT is indicated. This leads to prolonged periods of time where the patient must live without a new breast, inferior aesthetic outcomes, or an increase in complications. This phase 3 clinical trial, building on the PRADA pilot study, will investigate the efficacy and safety of preoperative RT combined with IBR. In this open-label, multicentre, phase 3, randomised controlled trial, 180 female participants with a new diagnosis of breast cancer will be enrolled. Participants will be randomised into two groups. The first group (control) will receive the standard of care treatment (SoC) consisting of mastectomy followed by PMRT; in this group the breast reconstruction can be either delayed or immediate. The second group (experimental) consists of preoperative RT followed by mastectomy and IBR. After treatment conclusion, follow-up will take place at 3 months, 1, 2, 5, and 10 years after the last study treatment. The primary outcome is the patient reported outcome measure of satisfaction with breasts (BREAST-Q score) at 1 year of follow-up. Secondary outcomes include cosmetic assessment, quality of life, adverse events, treatment duration, and histopathology response rates, tertiary endpoints include oncological survival outcomes according to DATECAN definitions. The trial sponsor is ZAS vzw, and is funded by ‘Kom op tegen kanker’. Preoperative RT has been implemented in multiple other types of cancer and could offer an opportunity to improve aesthetic and quality of life outcomes in breast cancer patients. Based on the PRADA pilot study and similar research, no increase in adverse events or worse oncological outcomes is expected from this change in treatment sequence. ClinicalTrials.gov: NCT06739655; First registration: 17-DEC-2024. Local ZAS Augustinus trial-ID: CTO23023GZA; First registration: 22-APR-2024.